Part Used : -
Activity : DRUG INTERACTION
Solvent/Active Compound : -
Type of experiment : in vivo
Type of animal : -
N(Total) : -
N(Treatment) : -
Route : Non-specified
Dose/Conc.(herb) : 1 micromolar
Duration : -
Type of interaction : Pharmacodynamics
Interaction with drug : Cyclophosphamide*/CPM/CTX/CYT
Dose/Conc.(drug) : -
Remark : Using an in vivo model of human breast cancer, dietary supplementation with curcumin was found to significantly inhibit cyclophosphamide-induced tumor regression. Such dietary supplementation was accompanied by a decrease in the activation of apoptosis by cyclophosphamide, as well as decreased the c-Jun NH2-terminal Kinase (JNK) activation.